首页> Cell reports. Medicine> Bioengineering of a human iPSC-derived vascularized endocrine pancreas for type 1 diabetes.

Bioengineering of a human iPSC-derived vascularized endocrine pancreas for type 1 diabetes.

导出 LinkOut

翻译打印收藏纠错

第一作者： Francesco,Campo

第一单位： San Raffaele Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy; Università Vita-Salute San Raffaele, Milan, Italy.

作者： Francesco,Campo ^[1] ; Alessia,Neroni ^[1] ; Cataldo,Pignatelli ^[2] ; Silvia,Pellegrini ^[2] ; Ilaria,Marzinotto ^[2] ; Libera,Valla ^[3] ; Fabio,Manenti ^[2] ; Martina,Policardi ^[2] ; Vito,Lampasona ^[2] ; Lorenzo,Piemonti ^[1] ; Antonio,Citro ^[4]

作者单位： San Raffaele Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy; Università Vita-Salute San Raffaele, Milan, Italy. ^[1] San Raffaele Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. ^[2] San Raffaele Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy; Chair for Molecular Animal Breeding and Biotechnology, Gene Center and Department of Veterinary Sciences, LMU Munich, 81377 Munich, Germany; Center for Innovative Medical Models (CiMM), LMU Munich, 85764 Oberschleißheim, Germany. ^[3] San Raffaele Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: citro.antonio@hsr.it. ^[4]

关键词 beta cell replacement extracellular matrix human iPSC vascularized endocrine spheroids iPSCs induced pluripotent stem cells islet transplantation lung scaffold organ decellularization organ engineering for type 1 diabetes pancreas bioengineering tissue engineering type 1 diabetes